Germany · Delayed Price · Currency is EUR MPH Health Care AG Statistics
Total Valuation
FRA:93M1 has a market cap or net worth of EUR 118.17 million. The enterprise value is 120.64 million.
| Market Cap | 118.17M |
| Enterprise Value | 120.64M |
Important Dates
The last earnings date was Wednesday, May 27, 2026.
| Earnings Date | May 27, 2026 |
| Ex-Dividend Date | Jul 10, 2026 |
Share Statistics
FRA:93M1 has 4.28 million shares outstanding.
| Current Share Class | 4.28M |
| Shares Outstanding | 4.28M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.56% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 3.17 |
| PS Ratio | 2.35 |
| PB Ratio | 0.49 |
| P/TBV Ratio | 0.49 |
| P/FCF Ratio | 960.59 |
| P/OCF Ratio | 902.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.47, with an EV/FCF ratio of 980.71.
| EV / Earnings | n/a |
| EV / Sales | 2.40 |
| EV / EBITDA | 2.47 |
| EV / EBIT | 2.48 |
| EV / FCF | 980.71 |
Financial Position
The company has a current ratio of 0.16, with a Debt / Equity ratio of 0.01.
| Current Ratio | 0.16 |
| Quick Ratio | 0.11 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 27.76 |
| Interest Coverage | 92.27 |
Financial Efficiency
Return on equity (ROE) is -11.25% and return on invested capital (ROIC) is 19.82%.
| Return on Equity (ROE) | -11.25% |
| Return on Assets (ROA) | 11.09% |
| Return on Invested Capital (ROIC) | 19.82% |
| Return on Capital Employed (ROCE) | 19.54% |
| Weighted Average Cost of Capital (WACC) | 10.34% |
| Revenue Per Employee | 25.09M |
| Profits Per Employee | -14.66M |
| Employee Count | 2 |
| Asset Turnover | 0.18 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FRA:93M1 has paid 306,804 in taxes.
| Income Tax | 306,804 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +39.49% in the last 52 weeks. The beta is 1.10, so FRA:93M1's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | +39.49% |
| 50-Day Moving Average | 22.32 |
| 200-Day Moving Average | 20.70 |
| Relative Strength Index (RSI) | 71.77 |
| Average Volume (20 Days) | 106 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:93M1 had revenue of EUR 50.18 million and -29.33 million in losses.
| Revenue | 50.18M |
| Gross Profit | 50.18M |
| Operating Income | 48.73M |
| Pretax Income | -29.02M |
| Net Income | -29.33M |
| EBITDA | 48.79M |
| EBIT | 48.73M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 939,241 in cash and 3.41 million in debt, with a net cash position of -2.48 million or -0.58 per share.
| Cash & Cash Equivalents | 939,241 |
| Total Debt | 3.41M |
| Net Cash | -2.48M |
| Net Cash Per Share | -0.58 |
| Equity (Book Value) | 243.41M |
| Book Value Per Share | n/a |
| Working Capital | -7.28M |
Cash Flow
In the last 12 months, operating cash flow was 130,875 and capital expenditures -7,861, giving a free cash flow of 123,014.
| Operating Cash Flow | 130,875 |
| Capital Expenditures | -7,861 |
| Depreciation & Amortization | 51,382 |
| Net Borrowing | -1.72M |
| Free Cash Flow | 123,014 |
| FCF Per Share | 0.03 |
Margins
Gross margin is 100.00%, with operating and profit margins of 97.12% and -58.44%.
| Gross Margin | 100.00% |
| Operating Margin | 97.12% |
| Pretax Margin | -57.83% |
| Profit Margin | -58.44% |
| EBITDA Margin | 97.22% |
| EBIT Margin | 97.12% |
| FCF Margin | 0.25% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 18.12%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 18.12% |
| Dividend Growth (YoY) | 316.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 17.92% |
| Earnings Yield | -24.82% |
| FCF Yield | 0.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 22, 2020. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 22, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |